New pill shows promise for controlling acromegaly Long-Term
NCT ID NCT04261712
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This study looks at the long-term safety and effectiveness of an oral medication called paltusotine for people with acromegaly, a condition where the body makes too much growth hormone. Participants are adults who have already completed a related study. The goal is to see if the drug can keep hormone levels under control over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Crinetics Study Site
Los Angeles, California, 90095, United States
-
Crinetics Study Site
Chicago, Illinois, 60611, United States
-
Crinetics Study Site
Boston, Massachusetts, 02114, United States
-
Crinetics Study Site
Columbus, Ohio, 43210, United States
-
Crinetics Study Site
Pittsburgh, Pennsylvania, 15212, United States
-
Crinetics Study Site
Pittsburgh, Pennsylvania, 15213, United States
-
Crinetics Study Site
Dallas, Texas, 75231, United States
-
Crinetics Study Site
Curitiba, Paraná, 80030-110, Brazil
-
Crinetics Study Site
Rio de Janeiro, 20231, Brazil
-
Crinetics Study Site
Rio de Janeiro, 21941, Brazil
-
Crinetics Study Site
São Paulo, 01228, Brazil
-
Crinetics Study Site
München, 80336, Germany
-
Crinetics Study Site
Athens, 10676, Greece
-
Crinetics Study Site
Thessaloniki, 54642, Greece
-
Crinetics Study Site
Budapest, 1062, Hungary
-
Crinetics Study Site
Budapest, 1083, Hungary
-
Crinetics Study Site
Pécs, 7624, Hungary
-
Crinetics Study Site
Belgrade, 11000, Serbia
-
Crinetics Study Site
Coventry, United Kingdom
-
Crinetics Study Site
Leeds, LS97TF, United Kingdom
-
Crinetics Study Site 1
Athens, 11527, Greece
-
Crinetics Study Site 2
Athens, 11527, Greece
Conditions
Explore the condition pages connected to this study.